Medication Prescribing

A study presented at American Podiatric Medical Association 2025 Annual Scientific Meeting explores how pain severity shapes daily burden, treatment experiences, and trial preferences among individuals...

Adding subcutaneous insulin degludec early to IV insulin may accelerate diabetic ketoacidosis resolution and improve glycemic outcomes without added risk.

A randomized, double-blind, placebo-controlled crossover study found that a single 300 mg dose of palmitoylethanolamide significantly reduced acute menstrual pain compared with placebo at multiple early...

In this expert interview, Tugce Akcan, MD, discusses a novel approach to type 1 diabetes care using OpenAPS and GLP-1 receptor agonists to eliminate the need for prandial insulin boluses and improve patient...

A phase 3b trial evaluated as-needed albuterol–budesonide versus albuterol alone in patients with uncontrolled mild asthma.

A phase 2 study evaluating the safety and efficacy of letrozole, abemaciclib, and metformin in treating estrogen receptor–positive recurrent endometrial cancer highlights promising outcomes in a select...

A post hoc analysis of the DUO-E trial evaluated how durvalumab and maintenance olaparib influenced circulating tumor DNA dynamics in first-line endometrial cancer treatment.

At the American Association of Clinical Endocrinology 2025 Annual Meeting, Jaime Almandoz, MD, MBA, FTOS, discussed the importance of continuing medical treatment for patients with obesity following...

At the American Association of Clinical Endocrinology 2025 Annual Meeting, Daniel Drucker, OC, MD, FRCPC, FRSC, FRS, discussed the evolving scope of GLP-1–based therapies, highlighting emerging molecules,...

In a cross-sectional survey presented at the American Academy of Pain Medicine PainConnect 2025 annual meeting in Austin, TX, researchers found that nearly 2 in 5 patients reported inadequate pain relief...